About this Research Topic
Molecular diagnostic assays are routinely performed in human oncology for the purpose of tumor classification, prognostication, identification of therapeutic targets, and patient-specific tailoring of therapy. Molecular oncology is recently emerging in veterinary medicine, however techniques such as mutation detection, RNA sequencing, metabolomics and proteomics are not routinely integrated into cancer diagnostic testing, except for a few tumors, such as polymerase chain reaction testing for canine lymphoma. Many questions remain unanswered regarding how molecular genetics or cell biologic functions, such as signaling pathways, relate to oncogenic transformation, oncopathogenesis, diagnosis, staging, medical treatment, and prognostication of tumors in veterinary medicine.
We invite you to submit your research on topics relevant to molecular oncology, including, but not limited to tumor classification and characterization, tumor biomarker research, understanding cancer formation and pathogenesis, and discovery of potential prognostic markers and new treatment strategies in dogs, cats, horses, and any other veterinary species. Research with a comparative or translational human pathology perspective will also be considered.
Keywords: Cancer, Genetics, Pathogenesis, Prognosis, Targeted Therapeutics
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.